Accreditation of Biosafe Clinical-Grade Human Embryonic Stem Cells According to Chinese Regulations
Authors:
Open Access
- 1 July 2017
- journal article
- Published by Elsevier in Stem Cell Reports
- Vol. 9 (1) , 366-380
Abstract
No abstract availableKeywords
Funding Information
- China National Basic Research Program (2013CB967100)
- National Key Research and Development Program of China (2016YFA0101502)
This publication has 43 references indexed in Scilit:
- Mesp1 Patterns Mesoderm into Cardiac, Hematopoietic, or Skeletal Myogenic Progenitors in a Context-Dependent MannerCell Stem Cell, 2013
- The NIH Stem Cell Registry: An Absence of Gamete Donor ConsentCell Stem Cell, 2013
- Derivation of Xeno-Free and GMP-Grade Human Embryonic Stem Cells – Platforms for Future Clinical ApplicationsPLOS ONE, 2012
- Regulations and guidelines governing stem cell based products: Clinical considerationsPerspectives in Clinical Research, 2011
- Highly Efficient Generation of Human Hepatocyte–Like Cells From Induced Pluripotent Stem CellsHepatology, 2009
- Efficient generation of hepatocyte-like cells from human induced pluripotent stem cellsCell Research, 2009
- Derivation of human embryonic stem cell lines from parthenogenetic blastocystsCell Research, 2007
- Human embryonic stem cell lines derived from single blastomeresNature, 2006
- Feeder-independent culture of human embryonic stem cellsNature Methods, 2006
- γ-Irradiation-induced cell cycle arrest and cell death in a human submandibular gland cell line: Effect of E2F1 expressionJournal of Cellular Physiology, 1998